Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 06, 2026
Uber (UBER) Q2 2026: +24% Gross Bookings Growth Meets Soft Q3 Guidance

Uber (UBER) Q2 2026: +24% Gross Bookings Growth Meets Soft Q3 Guidance

Key Takeaways

  • Revenue reached $14.19 billion in Q2 2026, up 12% year-over-year, though slightly below the $14.24 billion consensus estimate.
  • Non-GAAP EPS (earnings per share) came in at $0.81, up 35% year-over-year and roughly in line with analyst expectations.
  • Gross Bookings surged 24% year-over-year to $58.0 billion, surpassing Wall Street estimates of approximately $57.2 billion, fueled by World Cup-related travel demand.
  • Q3 guidance disappointed investors, with the Gross Bookings midpoint of $59.25 billion and Non-GAAP EPS forecast of $0.84 to $0.88 both coming in below Street averages.
  • Free cash flow reached $2.8 billion for the quarter, pushing trailing twelve-month free cash flow above $10 billion for the first time in the company's history.
  • Shares declined approximately 3% to 5% in the trading session following the release as the market digested the weaker forward outlook.

Earnings Context and Why It Matters

UBER’s second-quarter 2026 results arrived at a pivotal moment for the ride-hailing and delivery platform. Shares had already fallen roughly 14% year-to-date amid concerns over robotaxi competition and the risks surrounding the recently announced $14.8 billion acquisition of Delivery Hero. The report also came against a backdrop of investor focus on consumer spending trends and fuel cost pressures tied to geopolitical tensions in the Middle East. As one of the largest players in global mobility and delivery, UBER’s performance offers a useful read on discretionary demand and the gig economy’s trajectory. The mixed quarter—solid operational metrics paired with softer forward guidance—illustrates the balance the company must strike between growth and market expectations.

To get a broader view of how UBER compares with peers, I ran a quick screen with Tickeron’s AI tools.

Reported Results

UBER posted Q2 2026 revenue of $14.19 billion, reflecting 12% year-over-year growth (11% on a constant currency basis). The result edged below the consensus estimate of roughly $14.24 billion, partly due to business model changes that reduced reported revenue growth by about 8 percentage points. Gross Bookings reached $58.0 billion, up 24% year-over-year and 22% on a constant currency basis, beating analyst projections. Trips grew 18% year-over-year to 3.9 billion, supported by a 16% rise in Monthly Active Platform Consumers (MAPCs) to 208 million.

On profitability, Non-GAAP EPS was $0.81, up 35% from $0.60 in the prior-year period and in line with consensus. Non-GAAP operating income rose 40% year-over-year to $2.1 billion, while Adjusted EBITDA climbed 33% to $2.8 billion. GAAP net income reached $2.4 billion, including a $1.6 billion net benefit from the revaluation of equity investments. Operating cash flow was $2.9 billion, and free cash flow of $2.8 billion lifted the trailing twelve-month total above $10 billion for the first time.

Looking ahead, UBER guided Q3 2026 Gross Bookings to a range of $58.25 billion to $60.25 billion and Non-GAAP EPS to $0.84–$0.88. Both ranges came in below the midpoint of consensus estimates. Management also highlighted intensifying competition in Brazil—its largest market by trip volume—as a factor that tempered trip growth during the quarter.

Market Reaction and Investor Sentiment

UBER shares reacted negatively to the report, declining approximately 3% to 5% on August 5, 2026. The move reflected a classic “beat and drop” dynamic: while Gross Bookings exceeded expectations and profitability improved, the revenue miss and softer Q3 guidance set the tone. The options market had priced in a roughly 7% move in either direction, so the actual reaction stayed within expected volatility. Sentiment was further pressured by competition concerns in Brazil and integration risks tied to the Delivery Hero deal. Analysts stayed largely constructive, with BMO Capital reiterating a Buy rating and $119 price target, yet the near-term response showed investor sensitivity to any slowdown in momentum.

Forward Outlook and Key Factors to Monitor

UBER’s Q2 results set the stage for a critical second half of 2026. Several factors will shape the path ahead.

The integration of Delivery Hero stands out as a major but complex step. The $14.8 billion acquisition should expand delivery reach in Europe and Asia, yet execution risks, regulatory issues, and potential dilution remain. Management updates on timelines and synergies will be important for confidence.

Competitive pressure in Brazil and other core markets also deserves attention. Brazil is UBER’s largest market by trips, and management linked the modest deceleration in trip growth to rising competition there. Any escalation in pricing or driver incentives could affect margins.

Autonomous vehicle partnerships continue to develop. UBER has positioned itself as a platform for autonomous ride-hailing through multiple developer agreements. Updates on deployment timelines could serve as meaningful catalysts.

Macro factors such as fuel prices, consumer spending, and currency moves also matter. With Adjusted EBITDA margins reaching 4.9% of Gross Bookings, the company has shown operating leverage, but sustaining that will require steady demand and cost control. The Q3 guidance reset reflects a pragmatic stance, and investors will watch for a return to consistent beats and raises in coming quarters.

Using Tickeron’s AI Screener for Earnings Analysis

In my own research process, Tickeron’s AI Screener has become a regular part of reviewing earnings season. It lets me scan thousands of stocks and ETFs with customizable filters on fundamentals, technical patterns, and AI signals, helping surface context around names like UBER more efficiently than manual checks alone.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: UBER

UBER's RSI Oscillator ascends from oversold territory

The RSI Oscillator for UBER moved out of oversold territory on July 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 20 similar instances when the indicator left oversold territory. In of the 20 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UBER advanced for three days, in of 292 cases, the price rose further within the following month. The odds of a continued upward trend are .

UBER may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on August 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UBER as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for UBER turned negative on August 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

UBER moved below its 50-day moving average on August 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for UBER crossed bearishly below the 50-day moving average on July 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UBER declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for UBER entered a downward trend on August 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UBER’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.081) is normal, around the industry mean (27.954). P/E Ratio (14.952) is within average values for comparable stocks, (81.868). UBER's Projected Growth (PEG Ratio) (7.555) is very high in comparison to the industry average of (1.680). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (2.578) is also within normal values, averaging (52.021).

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Datadog (NASDAQ:DDOG), Intuit (NASDAQ:INTU), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Zoom Communications Inc (NASDAQ:ZM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.01B. The market cap for tickers in the group ranges from 291 to 222.3B. SAP holds the highest valuation in this group at 222.3B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 7%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 6%. YXT experienced the highest price growth at 686%, while YAAS experienced the biggest fall at -85%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was 47% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 77
Price Growth Rating: 57
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
UBER
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which provides a ride hailing services, develops applications for road transportation, navigation, ride sharing, and payment processing solutions.

Industry PackagedSoftware

Profile
Details
Industry
Packaged Software
Address
1725 3rd Street
Phone
+1 415 612-8582
Employees
30400
Web
https://www.uber.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.